HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lyell, D. J. Articles by El-Sayed, Y. Y. Search for Related Content PubMed PubMed Citation Articles by Lyell, D. J. Articles by El-Sayed, Y. Y. Related Collections General obstetrics Preterm labor

Magnesium Sulfate Compared With Nifedipine for Acute Tocolysis of Preterm Labor

A Randomized Controlled Trial

From the Departments of Obstetrics and Gynecology, ¹Stanford University Medical Center, Lucile S. Packard Children’s Hospital, Stanford, California; ²Santa Clara Valley Medical Center, Santa Clara, California; ³Palo Alto Medical Foundation, Fremont, California; and ⁴University of California San Francisco, San Francisco, California.

OBJECTIVE: To compare the efficacy and side effects of intravenous magnesium to oral nifedipine for acute tocolysis of preterm labor.

METHODS: A multicenter randomized trial was performed. Patients in active preterm labor who were at 24 to 33 weeks and 6 days of gestation were randomly assigned to receive magnesium sulfate or nifedipine. The primary outcome was arrest of preterm labor, defined as prevention of delivery for 48 hours with uterine quiescence.

RESULTS: One hundred ninety-two patients were enrolled. More patients assigned to magnesium sulfate achieved the primary outcome (87% compared with 72%, P=.01). There were no differences in delivery within 48 hours (7.6% magnesium sulfate compared with 8.0% nifedipine, P=.92), gestational age at delivery (35.8 compared with 36.0 weeks, P=.61), birth before 37 and 32 weeks (57% compared with 57%, P=.97, and 11% compared with 8%, P=.39), and episodes of recurrent preterm labor. Mild and severe maternal adverse effects were significantly more frequent with magnesium sulfate. Birth weight, birth weight less than 2,500 g, and neonatal morbidities were similar between groups, but newborns in the magnesium sulfate group spent longer in the neonatal intensive care unit (8.8±17.7 compared with 4.2±8.2 days, P=.007).

CONCLUSION: Patients who received magnesium sulfate achieved the primary outcome more frequently. However, delay of delivery, gestational age at delivery, and neonatal outcomes were similar between groups. Nifedipine was associated with fewer maternal adverse effects.

CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov, www.clinicaltrials.gov, NCT00185900

LEVEL OF EVIDENCE: I

This article has been cited by other articles:

				A. H. Nassar and I. M. Usta Magnesium Sulfate Compared With Nifedipine for Acute Tocolysis of Preterm Labor: A Randomized Controlled Trial Obstet. Gynecol., November 1, 2007; 110(5): 1170 - 1171. [Full Text] [PDF]